
Pharos iBT applies large-scale data analysis to discover and develop new drugs in practical, non-jargon terms. The company combines biotechnology research with IT-driven big data analytics and computational methods to identify targets and advance drug candidates. Pharos iBT operates as a drug discovery and development biotech, using data engineering, statistical analysis, and computational biology tools. Its offerings target pharmaceutical and biotech organizations seeking data-driven discovery capabilities. The company addresses the growing market for computationally enabled drug R&D and partnering services.

Pharos iBT applies large-scale data analysis to discover and develop new drugs in practical, non-jargon terms. The company combines biotechnology research with IT-driven big data analytics and computational methods to identify targets and advance drug candidates. Pharos iBT operates as a drug discovery and development biotech, using data engineering, statistical analysis, and computational biology tools. Its offerings target pharmaceutical and biotech organizations seeking data-driven discovery capabilities. The company addresses the growing market for computationally enabled drug R&D and partnering services.